Long Ideas - Cornerstone Therapeutics (NASDAQ:CRTX) has renegotiated a distribution agreement with partner and majority shareholder Chiesi Farmaceutici, an Italian pharmaceutical company, which according to the company, should … Continue Reading
Read NowLong Ideas - Updated at 11:00AM, 12/20/12. Shares of Illumina (ILMN) climbed 7% in the pre-market on news that Roche (RHHBY) may have revised higher its previous buy-out … Continue Reading
Read NowLong Ideas - Shares of Questcor Pharmaceuticals (NASDAQ:QCOR), despite a large short interest, have continued to perform well for shareholders and broke through several resistance levels this week to … Continue Reading
Read NowLong Ideas - Pacira Pharmaceuticals (NASDAQ:PCRX) reported on Tuesday morning that, based on the results of a regional health system analysis conducted by Barnabas Health, opioid use in … Continue Reading
Read NowLong Ideas - For biotechnology investors, a biotechnology company’s “pivot” period, the time frame when it transitions from a development-stage company to a solidly profitable company can often … Continue Reading
Read NowLong Ideas - Orexigen Therapeutics (OREX) will be the last of three leading weight-loss drug developers to enter the large potential market for new obesity treatments, and biotech … Continue Reading
Read NowLong Ideas - ArQule (NASDAQ:ARQL) has enrolled the first patient in its Phase I trial of the FGFR Inhibitor ARQ-087, the last of five oncology products that the … Continue Reading
Read Now